{"id":"https://openalex.org/W1156867599","doi":"https://doi.org/10.1212/wnl.84.14_supplement.p1.113","title":"Quality of life perceptions correlate with longitudinal clinical relapse reduction metrics in patients treated with subcutaneous interferon beta-1a given three times a week. (P1.113)","display_name":"Quality of life perceptions correlate with longitudinal clinical relapse reduction metrics in patients treated with subcutaneous interferon beta-1a given three times a week. (P1.113)","publication_year":2015,"publication_date":"2015-04-06","ids":{"openalex":"https://openalex.org/W1156867599","doi":"https://doi.org/10.1212/wnl.84.14_supplement.p1.113","mag":"1156867599"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.84.14_supplement.p1.113","doi":"https://doi.org/10.1212/wnl.84.14_supplement.p1.113","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.84.14_supplement.p1.113","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087386592","display_name":"Barbara E. Teter","orcid":"https://orcid.org/0000-0003-1527-6192","observed_orcids":["https://orcid.org/0000-0003-1527-6192"]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Teter","raw_affiliation_strings":["Jacobs MS Treatment and Research Center Buffalo NY United States","Neurology SUNY-University of Buffalo SMBS Buffalo NY United States","New York State Multiple Sclerosis Consortium Buffalo NY United States","6Neurology SUNY-University of Buffalo SMBS Buffalo NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jacobs MS Treatment and Research Center Buffalo NY United States","institution_ids":[]},{"raw_affiliation_string":"Neurology SUNY-University of Buffalo SMBS Buffalo NY United States","institution_ids":["https://openalex.org/I63190737"]},{"raw_affiliation_string":"New York State Multiple Sclerosis Consortium Buffalo NY United States","institution_ids":[]},{"raw_affiliation_string":"6Neurology SUNY-University of Buffalo SMBS Buffalo NY United States","institution_ids":["https://openalex.org/I63190737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033859874","display_name":"Katelyn S. Kavak","orcid":"https://orcid.org/0000-0001-5062-8275","observed_orcids":["https://orcid.org/0000-0001-5062-8275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katelyn Kavak","raw_affiliation_strings":["Jacobs MS Treatment and Research Center Buffalo NY United States","New York State Multiple Sclerosis Consortium Buffalo NY United States","4New York State Multiple Sclerosis Consortium Buffalo NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jacobs MS Treatment and Research Center Buffalo NY United States","institution_ids":[]},{"raw_affiliation_string":"New York State Multiple Sclerosis Consortium Buffalo NY United States","institution_ids":[]},{"raw_affiliation_string":"4New York State Multiple Sclerosis Consortium Buffalo NY United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010771032","display_name":"Fernando Dangond","orcid":"https://orcid.org/0000-0002-6723-4229","observed_orcids":["https://orcid.org/0000-0002-6723-4229"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando Dangond","raw_affiliation_strings":["US Medical Affairs Neurodegenerative Diseases EMD Serono, Inc. Weston MA United States","1US Medical Affairs Neurodegenerative Diseases EMD Serono, Inc. Weston MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Medical Affairs Neurodegenerative Diseases EMD Serono, Inc. Weston MA United States","institution_ids":["https://openalex.org/I4210111614"]},{"raw_affiliation_string":"1US Medical Affairs Neurodegenerative Diseases EMD Serono, Inc. Weston MA United States","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075596287","display_name":"Bianca Weinstock\u2010Guttman","orcid":"https://orcid.org/0000-0001-6732-151X","observed_orcids":["https://orcid.org/0000-0001-6732-151X"]},"institutions":[{"id":"https://openalex.org/I63190737","display_name":"University at Buffalo, State University of New York","ror":"https://ror.org/01y64my43","country_code":"US","type":"education","lineage":["https://openalex.org/I63190737"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bianca Weinstock-Guttman","raw_affiliation_strings":["Jacobs MS Center and Pediatric MS Center of Excellence Buffalo NY United States","Neurology SUNY-University of Buffalo SMBS Buffalo NY United States","New York State Multiple Sclerosis Consortium Buffalo NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jacobs MS Center and Pediatric MS Center of Excellence Buffalo NY United States","institution_ids":[]},{"raw_affiliation_string":"Neurology SUNY-University of Buffalo SMBS Buffalo NY United States","institution_ids":["https://openalex.org/I63190737"]},{"raw_affiliation_string":"New York State Multiple Sclerosis Consortium Buffalo NY United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.02343308,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"14_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/interferon-beta-1a","display_name":"interferon beta-1a","score":0.9760000109672546},{"id":"https://openalex.org/keywords/subcutaneous-interferon-therapy","display_name":"subcutaneous interferon therapy","score":0.8849999904632568},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9430000185966492},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.7400000095367432},{"id":"https://openalex.org/keywords/annualized-relapse-rate","display_name":"annualized relapse rate","score":0.9440000057220459},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.921999990940094},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.3880000114440918}],"concepts":[{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.5954185724258423},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5548386573791504},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.48098456859588623},{"id":"https://openalex.org/C26760741","wikidata":"https://www.wikidata.org/wiki/Q160402","display_name":"Perception","level":2,"score":0.47723984718322754},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4723980128765106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4501153230667114},{"id":"https://openalex.org/C111335779","wikidata":"https://www.wikidata.org/wiki/Q3454686","display_name":"Reduction (mathematics)","level":2,"score":0.44666820764541626},{"id":"https://openalex.org/C2777895361","wikidata":"https://www.wikidata.org/wiki/Q1758614","display_name":"Longitudinal study","level":2,"score":0.4265870451927185},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.27790355682373047},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.23598209023475647},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.13201767206192017},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.11545231938362122},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.09485247731208801},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.07346820831298828},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.054164737462997437},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.84.14_supplement.p1.113","doi":"https://doi.org/10.1212/wnl.84.14_supplement.p1.113","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.84.14_supplement.p1.113","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1970572709","https://openalex.org/W2413721625","https://openalex.org/W1974725626","https://openalex.org/W2412943421","https://openalex.org/W1965984646","https://openalex.org/W2043447672","https://openalex.org/W2134558833","https://openalex.org/W1986766916","https://openalex.org/W1488359481","https://openalex.org/W2324187974"],"abstract_inverted_index":{"Objective:":[0],"Investigate":[1],"the":[2,13,52,69,90,96,144,150,201,205,262,269,284,292],"association":[3],"between":[4,41,89,149],"patients\u2019":[5],"perceived":[6,46],"improvement":[7,224],"in":[8,95,176,225,271],"quality":[9,47,137,211],"of":[10,20,48,51,138,189,195,212,215,253,294],"life":[11,49,139,213,242],"and":[12,44,147,227,241],"relapse":[14,92,162,272],"rate":[15,93,184,273],"reduction":[16,175],"among":[17],"a":[18,34,110,250],"group":[19,207,219],"multiple":[21],"sclerosis":[22],"(MS)":[23],"patients":[24,157,254,275],"on":[25,63,197,274,276],"subcutaneous":[26],"(SC)":[27],"interferon":[28],"beta":[29],"1-a":[30],"(IFN\u03b2-1a)":[31],"three":[32],"times":[33],"week":[35],"(tiw)":[36],"therapy.":[37,198,280],"Background:":[38],"The":[39,217],"relationship":[40],"clinical":[42,55,152,264],"symptoms":[43],"patient":[45,257],"outside":[50],"controlled":[53],"environment":[54],"trial":[56],"is":[57],"not":[58],"yet":[59],"elucidated.":[60],"Methods:":[61],"Patients":[62,118],"IFN\u03b2-1a":[64,82,100,159,179,187,278],"therapy":[65,107],"were":[66,119,141,164],"extracted":[67],"from":[68,249,283],"New":[70],"York":[71],"State":[72],"MS":[73],"Consortium":[74],"(NYSMSC)":[75],"registry.":[76],"Complete":[77],"two-year":[78],"follow-up":[79,145],"data":[80,282],"after":[81],"initiation":[83,101,108,188],"was":[84,129,208],"examined":[85,148],"to":[86,102,192,200,268],"determine":[87],"differences":[88],"annualized":[91],"(ARR)":[94],"year":[97,105],"preceding":[98],"SC":[99,186,277],"\u8805":[103],"1":[104],"following":[106],"using":[109,158],"Poisson":[111],"log":[112],"linear":[113],"repeated":[114],"measures":[115],"regression":[116],"model.":[117],"categorized":[120],"into":[121],"two":[122,151],"groups,":[123],"those":[124,132],"whose":[125,133],"ARR":[126,134,183,194],"improved":[127,263],"or":[128,223],"stable":[130],"vs.":[131],"worsened.":[135],"Self-reported":[136],"variables":[140],"measured":[142],"over":[143],"period":[146],"metric":[153],"groups.":[154],"Results:":[155],"54":[156],"with":[160,181,210],"complete":[161],"history":[163],"available":[165],"for":[166],"initial":[167],"assessment.":[168],"Regression":[169],"analyses":[170],"show":[171],"an":[172,182,193],"approximate":[173],"42[percnt]":[174],"relapses":[177],"by":[178],"treatment,":[180],"before":[185],"0.90\u00b10.65,":[190],"compared":[191],"0.52\u00b10.72":[196],"Compared":[199],"clinically":[202],"worsened":[203],"group,":[204],"improved/stable":[206,218],"associated":[209],"indicators":[214],"improvement/stability.":[216],"reported":[220],"no":[221],"worsening":[222],"loneliness":[226],"pessimism":[228],"(80.5[percnt]),":[229],"irritation":[230],"(70.7[percnt]),":[231],"guilt":[232],"(82.5[percnt]),":[233],"morbid":[234],"thoughts":[235],"(87.8[percnt]),":[236],"pain":[237],"(100[percnt]),":[238],"fatigue":[239],"(75.0[percnt])":[240],"satisfaction":[243],"(85.0[percnt]).":[244],"Discussion:":[245],"These":[246],"preliminary":[247],"results":[248],"small":[251],"sample":[252],"showed":[255],"that":[256],"related":[258,267],"outcomes":[259],"can":[260],"corroborate":[261],"status":[265],"as":[266],"decrease":[270],"tiw":[279],"Additional":[281],"larger":[285],"NYSMSC":[286],"cohort":[287],"will":[288],"be":[289],"provided":[290],"at":[291],"time":[293],"presentation.":[295]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}